XML 49 R17.htm IDEA: XBRL DOCUMENT
v3.24.0.1

Stock-Based Compensation | 12 Months Ended
--- | ---
Dec. 31, 2023
Share-Based Payment Arrangement [Abstract] |
Stock-Based Compensation | Note H – Equity-Based Compensation In February 2019, the Company's Board of Directors approved the Steven Madden, Ltd. 2019 Incentive Compensation Plan (the “2019 Plan”), under which non-qualified stock options, stock appreciation rights, performance shares, restricted stock, other stock-based awards and performance-based awards may be granted to employees, consultants, and non-employee directors. The 2019 Plan is the successor to the Company's Amended and Restated 2006 Stock Incentive Plan, as amended (the "2006 Plan"), the term of which expired on April 6, 2019. The Company's stockholders approved the 2019 Plan at the Company's annual meeting of stockholders held on May 24, 2019. The following table summarizes the number of shares of common stock authorized for issuance under the 2019 Plan, the number of stock-based awards granted (net of expired or cancelled awards) under the 2019 Plan and the number of shares of common stock available for the grant of stock-based awards under the 2019 Plan:
(in thousands) |
Common stock authorized | 11,000 |
Stock-based awards, including restricted stock and stock options granted, net of expired or cancelled awards | (6,379) |
Common stock available for grant of stock-based awards as of December 31, 2023 | 4,621 |
In addition, vested and unvested options to purchase 76 shares of common stock and 255 shares of unvested restricted stock awarded under the 2006 Plan were outstanding as of December 31, 2023. For the years ended December 31, 2023, 2022, and 2021, total equity-based compensation was as follows:
| Years Ended December 31,
(in thousands) | 2023 |  | 2022 |  | 2021
Restricted stock | $ | 21,551 |  |  | $ | 21,005 |  |  | $ | 18,144 |
Stock options | 2,597 |  |  | 3,391 |  |  | 4,134 |
Total | $ | 24,148 |  |  | $ | 24,396 |  |  | $ | 22,278 |
We calculate an estimated forfeiture rate annually based on historical forfeiture and expectations about future forfeitures. Equity-based compensation is included in operating expenses on the Company’s Consolidated Statements of Income. Restricted Stock The following table summarizes restricted stock activity during the year ended December 31, 2023 and 2022:
(in thousands) | Number of Shares |  | Weighted Average Fair Value at Grant Date
Outstanding at January 1, 2022 | 2,849 |  |  | 23.81 |
Granted | 439 |  |  | 40.30 |
Vested | (1,144) |  |  | 21.25 |
Forfeited | (35) |  |  | 34.37 |
Outstanding at December 31, 2022 | 2,109 |  |  | $ | 28.44 |
Granted | 398 |  |  | 33.38 |
Vested | (1,192) |  |  | 22.38 |
Forfeited | (37) |  |  | 37.82 |
Outstanding at December 31, 2023 | 1,278 |  |  | $ | 35.44 |
As of December 31, 2023, the Company had $33,991 of total unrecognized compensation cost related to restricted stock awards granted under the 2019 Plan and the 2006 Plan. This cost is expected to be recognized over a weighted average period of 3.1 years. The Company determines the fair value of its restricted stock awards based on the market price of its common stock on the date of grant. The fair values of the restricted stock that vested during the years ended December 31, 2023, 2022, and 2021 were $26,168, $24,300, and $23,231, respectively. Stock Options Activity relating to stock options granted under the Company’s plans during the year ended December 31, 2023 was as follows:
(in thousands except for per share price) | Number of Shares |  | Weighted Average Exercise Price |  | Weighted Average Remaining Contractual Term |  | Aggregate Intrinsic Value
Outstanding at January 1, 2022 | 2,531 |  |  | $ | 29.06 |  |  |  |  |
Granted | 276 |  |  | $ | 36.95 |  |  |  |  |
Exercised | (24) |  |  | $ | 25.61 |  |  |  |  |
Forfeited | (17) |  |  | $ | 39.28 |  |  |  |  |
Outstanding at December 31, 2022 | 2,766 |  |  | $ | 29.82 |  |  | 2.0 years |  | $ | 11,778 |
Vested and Exercisable at December 31, 2022 | 2,543 |  |  | $ | 29.11 |  |  | 1.8 years |  | $ | 11,741 |
Outstanding at January 1, 2023 | 2,766 |  |  | $ | 29.82 |  |  |  |  |
Granted | 237 |  |  | 30.74 |  |  |  |  |
Exercised | (1,654) |  |  | 25.14 |  |  |  |  |
Expired | (229) |  |  | 36.01 |  |  |  |  |
Forfeited | (2) |  |  | 46.28 |  |  |  |  |
Outstanding at December 31, 2023 | 1,118 |  |  | $ | 35.62 |  |  | 3.2 years |  | $ | 7,684 |
Vested and Exercisable at December 31, 2023 | 935 |  |  | $ | 35.91 |  |  | 3.0 years |  | $ | 6,167 |
At December 31, 2023, $1,336 of total unrecognized compensation cost related to non-vested stock option awards is expected to be recognized over a weighted-average period of 1.4 years. Additional information pertaining to the Company's stock option plan was as follows:
| Years Ended December 31,
(in thousands) | 2023 |  | 2022 |  | 2021
Cash received from the exercise of stock options | $ | 1,205 |  |  | $ | 602 |  |  | $ | 9,732 |
Intrinsic value of stock options exercised | $ | 16,335 |  |  | $ | 314 |  |  | $ | 8,622 |
Tax benefits realized on exercise of stock options | $ | 1,285 |  |  | $ | 41 |  |  | $ | 1,512 |
The Company uses the Black-Scholes-Merton option-pricing model to estimate the fair value of options granted, which requires several assumptions. The expected term of the options represents the estimated period of time until exercise and is based on the historical experience of similar awards. Expected volatility is based on the historical volatility of the Company’s common stock. The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of the grant. The dividend yield is based on the Company's annualized dividend per share amount divided by the Company's stock price. New shares are issued upon option exercise. The following weighted average assumptions were used for stock options granted during 2023, 2022, and 2021:
| Years Ended December 31,
| 2023 |  | 2022 |  | 2021
Volatility | 37.3% to 48.1% |  | 42.5% to 51.1% |  | 40.3% to 49.6%
Risk free interest rate | 3.7% to 4.7% |  | 1.2% to 3.0% |  | 0.1% to 1.0%
Expected life in years | 3.0 to 5.0 |  | 3.0 to 5.0 |  | 2.0 to 4.0
Dividend yield | 2.5% |  | 2.1% |  | 1.4%
Weighted average fair value | $10.12 |  | $13.42 |  | $13.30

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//718/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h)(2) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h)(2)(i) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (l) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration